This document discusses the production and manufacturing of vaccines. It describes two main types of vaccine production: traditional egg-based methods and newer cell-based methods using mammalian cells. The egg-based methods have been used for 60 years to produce seasonal flu vaccines but they have disadvantages like mutations during adaptation and long production times. Cell-based methods using dog kidney cells or other mammalian cells have advantages like faster production and reduced mutations but they have higher costs. The document also mentions clinical development of vaccines during a pandemic is urgent to protect the public with limited time constraints.